Conjunctivitis in COVID-19 patients: frequency and clinical presentation


Downloads per month over past year




Downloads per month over past year

Güemes Villahoz, Noemi and Burgos Blasco, Bárbara and García Feijoo, Julián and Sáenz Francés, Federico and Arriola Villalobos, Pedro and Martínez de la Casa, José María and Benítez del Castillo, José Manuel and Herrera de la Muela, María (2020) Conjunctivitis in COVID-19 patients: frequency and clinical presentation. Graefe's Archive for Clinical and Experimental Ophthalmology . 7 p.. ISSN 0721-832X

[thumbnail of Martinez de la Casa_2020_Güemes-Villahoz2020_Article_ConjunctivitisInCOVID-19Patien.pdf] PDF
Restringido a Repository staff only


Official URL:


Purpose: The purpose of this study was to evaluate the frequency and clinical presentation of conjunctivitis in hospitalized patients with COVID-19.
Methods: A cross-sectional study was conducted at the Hospital Clinico San Carlos of Madrid, Spain. A total of 301 subjects from the COVID admission unit with laboratory-confirmed SARS-CoV-2 infection were included. The presence and clinical characteristics of conjunctivitis were evaluated. Laboratory, radiological, and clinical results in patients with and without conjunctivitis stratified by sex were analyzed.
Results: Of the 301 subjects included, 180 patients (59.8%) were male and the median age was 72 years (IQ 59–82). Overall, 35 patients (11.6%) were diagnosed with acute conjunctivitis. We found no relationship between the COVID-19 severity score and the presence of conjunctivitis (P = 0.17). However, conjunctivitis was more frequent in males with moderate clinical severity and in women classified as clinically mild. The natural history of the disease seems to be a rapid self-limited conjunctivitis that improves without treatment and does not affect visual acuity nor associate short-term complications.
Conclusions: Approximately, 1 out of 10 hospitalized non-critical COVID-19 patients presents conjunctivitis during the disease. Compared with other viral conjunctivitis, we found distinctive clinical findings that could guide defining and differentiating conjunctivitis in COVID-19 patients.

Item Type:Article
Additional Information:

Received: 1 June 2020 / Revised: 20 July 2020 /Accepted: 25 August 2020

Uncontrolled Keywords:Conjunctivitis; COVID-19; SARAS.CoV-2; Ocular; Coronavirus
Subjects:Medical sciences > Medicine > Communicable diseases
Medical sciences > Medicine > Ophtalmology
ID Code:62028
Deposited On:28 Sep 2020 11:14
Last Modified:28 Sep 2020 11:14

Origin of downloads

Repository Staff Only: item control page